CLK4 belongs to the family of cdc2-like kinases (CLKs) containing four isoforms namely CLK1, CLK2, CLK3 and CLK4. CLK1 has been considered as a potential target for Alzheimer’s disease drug development45. This evidence concerns the gene CLK1 and early-onset autosomal dominant Alzheimer disease.